Skip to content
PubMed This is a summary of 32 peer-reviewed journal articles Updated
Metabolic medicine

Abetalipoproteinemia: A Patient Guide

At a Glance

Abetalipoproteinemia is a rare inherited condition caused by an MTTP gene change that limits absorption and transport of dietary fat and vitamins A, D, E, and K. Lifelong supervised dietary planning, high-dose vitamins, and specialist monitoring can reduce neurological and vision complications.

Abetalipoproteinemia (ABL) is an exceptionally rare genetic condition that fundamentally changes how your body interacts with the food you eat. At its core, the condition is a “shipping failure” within your cells. Due to a mutation in the MTTP gene, your body has a severely impaired ability to produce a vital protein needed to package fats and essential vitamins into transport containers called lipoproteins. Without enough of these containers, dietary fats and critical fat-soluble vitamins—A, D, E, and K—are markedly reduced in absorption and transport, remaining largely in your intestinal cells and liver instead of entering your bloodstream to nourish your nerves, eyes, and organs [1][2].

Key Safety Point: Vitamin and dietary treatments for ABL require careful medical supervision. Do not start, stop, or change your high-dose vitamin supplements or diet on your own, as these vitamins can be toxic at high levels and require clinical monitoring.

This internal transport failure usually reveals itself early in life, often beginning in infancy with digestive distress. Because the body cannot effectively absorb fat, it reacts with symptoms like oily stools and difficulty gaining weight. If left unmanaged, the chronic lack of vitamins—particularly vitamin E—begins to affect the nervous system and the eyes over time. This can lead to challenges with balance and coordination, as well as gradual changes in vision. These symptoms represent the body’s signal that it is missing the essential nutrients required to maintain the health of its most delicate tissues [3][4].

Living with ABL requires a lifelong commitment to a specialized treatment strategy designed to bypass this biological bottleneck. The foundation of care involves an individualized low-long-chain-fat plan to prevent digestive complications, paired with specialized, supervised high doses of oral fat-soluble vitamins. Because your body absorbs only a tiny fraction of these supplements, the doses must be far higher than standard recommendations to ensure enough nutrients reach your system. When this regimen is started early and maintained consistently, many of the most serious neurological and visual complications can be stabilized, significantly delayed, or even prevented [5][6].

Because ABL affects multiple parts of the body, the most effective way to manage it is through a multidisciplinary care team. This team typically includes specialists in metabolism, nutrition, neurology, and ophthalmology, all working together to monitor your health and adjust your treatment as you grow. While the diagnosis is life-changing and the management is intensive, staying connected with experienced providers allows you to take a proactive role in your health. With modern management and careful monitoring, it is possible to navigate the challenges of ABL and lead a full, active life [7][8].

Common questions in this guide

What causes abetalipoproteinemia?
Abetalipoproteinemia is caused by inherited changes in the MTTP gene. These changes reduce production of a protein needed to package fat and fat-soluble vitamins into transport particles called lipoproteins, so the body cannot absorb and move them normally.
What symptoms can abetalipoproteinemia cause?
Symptoms often begin in infancy with digestive distress, oily stools, and difficulty gaining weight. Over time, low vitamin levels, especially low vitamin E, can contribute to balance and coordination problems and gradual changes in vision.
Why does abetalipoproteinemia require high-dose vitamins?
The body absorbs only a very small amount of vitamin supplements in abetalipoproteinemia, so doses may need to be much higher than standard recommendations. Vitamins A, D, E, and K can be harmful at high levels, which is why supplementation must be prescribed and monitored by a healthcare team.
What diet is used to manage abetalipoproteinemia?
Management usually includes an individualized eating plan that limits long-chain dietary fats to help reduce digestive complications. A registered dietitian or nutrition specialist familiar with severe fat-malabsorption disorders can help tailor the plan, and patients should not change it without medical guidance.
Can treatment prevent nerve and vision problems from abetalipoproteinemia?
When treatment is started early and followed consistently, specialized diet and vitamin therapy can stabilize, significantly delay, or sometimes prevent serious neurological and visual complications. Ongoing monitoring is needed because treatment is lifelong and needs may change over time.
Which specialists treat abetalipoproteinemia?
Abetalipoproteinemia is usually managed by a multidisciplinary team that may include specialists in metabolism, nutrition, neurology, and ophthalmology. Ask your healthcare team which clinician will coordinate care and how the plan will change when transitioning from pediatric to adult services.

Get notified when new evidence is published on Abetalipoproteinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Current Diagnosis and Management of Abetalipoproteinemia.

    Takahashi M, Okazaki H, Ohashi K, et al.

    Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.

    PMID: 33994405
  2. 2

    Lipid transfer proteins in the assembly of apoB-containing lipoproteins.

    Sirwi A, Hussain MM

    Journal of lipid research 2018; (59(7)):1094-1102 doi:10.1194/jlr.R083451.

    PMID: 29650752
  3. 3

    Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.

    Le R, Zhao L, Hegele RA

    Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.

    PMID: 35221233
  4. 4

    A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.

    Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.

    Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.

    PMID: 33258201
  5. 5

    Abetalipoproteinemia Due to a Novel Splicing Variant in MTTP in 3 Siblings.

    Vlasschaert C, McIntyre AD, Thomson LA, et al.

    Journal of investigative medicine high impact case reports 2021; (9()):23247096211022484 doi:10.1177/23247096211022484.

    PMID: 34078172
  6. 6

    Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.

    Triantafillidis JK, Manioti A, Pittaras T, et al.

    Journal of personalized medicine 2025; (15(8)) doi:10.3390/jpm15080354.

    PMID: 40863416
  7. 7

    Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?

    Sissaoui S, Cochet M, Poinsot P, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (73(1)):4-8 doi:10.1097/MPG.0000000000003145.

    PMID: 33853111
  8. 8

    A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.

    Valmiki S, Bredefeld C, Hussain MM

    Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.

    PMID: 39672332

This page is for educational purposes only and does not constitute medical advice. Because high-dose vitamins and dietary changes for abetalipoproteinemia require careful monitoring, consult your metabolic and nutrition specialists before changing treatment.